The obesity paradox: an endocrine perspective

Yee-Ming Cheung, Anju Joham, Sharon Marks, Helena Teede

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Obesity is a growing epidemic both in Australia and worldwide. Being overweight or obese is known to be adversely associated with multiple cardiovascular risk factors, such as type 2 diabetes mellitus, lipid disorders and hypertension. Despite the adverse impact of overweight and obesity, recent observational studies have suggested that in some overweight and obese individuals with established chronic disease, there is a survival advantage that is paradoxically better than individuals of normal weight. A burgeoning area of interest is the existence of this paradox in chronic endocrine disorders, especially with respect to osteoporosis and type 2 diabetes mellitus, as well as the latter's chronic complications, chronic kidney disease and coronary artery disease. In this article, we review the postulated mechanisms and latest evidence concerning the obesity paradox, with a focus on endocrine-related diseases. We discuss confounders and biases that exist in observational studies from which the paradox has been described and highlight that, despite the observed paradox, substantial literature exists supporting the benefits of weight reduction in obesity.

Original languageEnglish
Pages (from-to)727-733
Number of pages7
JournalInternal Medicine Journal
Volume47
Issue number7
DOIs
Publication statusPublished - 1 Jul 2017

Keywords

  • morbidity
  • mortality
  • obesity

Cite this

Cheung, Yee-Ming ; Joham, Anju ; Marks, Sharon ; Teede, Helena. / The obesity paradox : an endocrine perspective. In: Internal Medicine Journal. 2017 ; Vol. 47, No. 7. pp. 727-733.
@article{7a871770d9ea403c8259f589e62d4af2,
title = "The obesity paradox: an endocrine perspective",
abstract = "Obesity is a growing epidemic both in Australia and worldwide. Being overweight or obese is known to be adversely associated with multiple cardiovascular risk factors, such as type 2 diabetes mellitus, lipid disorders and hypertension. Despite the adverse impact of overweight and obesity, recent observational studies have suggested that in some overweight and obese individuals with established chronic disease, there is a survival advantage that is paradoxically better than individuals of normal weight. A burgeoning area of interest is the existence of this paradox in chronic endocrine disorders, especially with respect to osteoporosis and type 2 diabetes mellitus, as well as the latter's chronic complications, chronic kidney disease and coronary artery disease. In this article, we review the postulated mechanisms and latest evidence concerning the obesity paradox, with a focus on endocrine-related diseases. We discuss confounders and biases that exist in observational studies from which the paradox has been described and highlight that, despite the observed paradox, substantial literature exists supporting the benefits of weight reduction in obesity.",
keywords = "morbidity, mortality, obesity",
author = "Yee-Ming Cheung and Anju Joham and Sharon Marks and Helena Teede",
year = "2017",
month = "7",
day = "1",
doi = "10.1111/imj.13257",
language = "English",
volume = "47",
pages = "727--733",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "7",

}

The obesity paradox : an endocrine perspective. / Cheung, Yee-Ming; Joham, Anju; Marks, Sharon; Teede, Helena.

In: Internal Medicine Journal, Vol. 47, No. 7, 01.07.2017, p. 727-733.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - The obesity paradox

T2 - an endocrine perspective

AU - Cheung, Yee-Ming

AU - Joham, Anju

AU - Marks, Sharon

AU - Teede, Helena

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Obesity is a growing epidemic both in Australia and worldwide. Being overweight or obese is known to be adversely associated with multiple cardiovascular risk factors, such as type 2 diabetes mellitus, lipid disorders and hypertension. Despite the adverse impact of overweight and obesity, recent observational studies have suggested that in some overweight and obese individuals with established chronic disease, there is a survival advantage that is paradoxically better than individuals of normal weight. A burgeoning area of interest is the existence of this paradox in chronic endocrine disorders, especially with respect to osteoporosis and type 2 diabetes mellitus, as well as the latter's chronic complications, chronic kidney disease and coronary artery disease. In this article, we review the postulated mechanisms and latest evidence concerning the obesity paradox, with a focus on endocrine-related diseases. We discuss confounders and biases that exist in observational studies from which the paradox has been described and highlight that, despite the observed paradox, substantial literature exists supporting the benefits of weight reduction in obesity.

AB - Obesity is a growing epidemic both in Australia and worldwide. Being overweight or obese is known to be adversely associated with multiple cardiovascular risk factors, such as type 2 diabetes mellitus, lipid disorders and hypertension. Despite the adverse impact of overweight and obesity, recent observational studies have suggested that in some overweight and obese individuals with established chronic disease, there is a survival advantage that is paradoxically better than individuals of normal weight. A burgeoning area of interest is the existence of this paradox in chronic endocrine disorders, especially with respect to osteoporosis and type 2 diabetes mellitus, as well as the latter's chronic complications, chronic kidney disease and coronary artery disease. In this article, we review the postulated mechanisms and latest evidence concerning the obesity paradox, with a focus on endocrine-related diseases. We discuss confounders and biases that exist in observational studies from which the paradox has been described and highlight that, despite the observed paradox, substantial literature exists supporting the benefits of weight reduction in obesity.

KW - morbidity

KW - mortality

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=85021734698&partnerID=8YFLogxK

U2 - 10.1111/imj.13257

DO - 10.1111/imj.13257

M3 - Review Article

VL - 47

SP - 727

EP - 733

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 7

ER -